Company profilePharmaceutical#17 of 1,318 in Pakistan3 DRAP alerts

BOSCH PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 379 brands · 361 molecules

Ranked #2 of 137 companies in Anti-Infectives

379 registered products 89 pharmaceutical brands 361 distinct molecules 3 DRAP alerts

Company overview

379
registered products
89
pharmaceutical brands
361
distinct molecules
12
therapeutic classes
3
DRAP alerts

BOSCH PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 379 product registrations across 361 distinct molecules. It is the 17th largest registrant in Pakistan by product count, and ranks 2nd of 137 in Anti-Infectives. Its portfolio is concentrated in Anti-Infectives and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 3 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BOSCH

372 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Antihistamines For Systemic Use 3

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

281
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252
2026279

Top molecules by brand count

Ciprofloxacin14 brands
Amikacin12 brands
Amoxicillin11 brands
Eye10 brands
Levofloxacin7 brands
Aspirin7 brands
Azithromycin7 brands
Diclofenac7 brands
Cefixime6 brands
Artemether6 brands

Therapeutic classes

Anti-Infectives · 22Other Beta-Lactam, Cephalosporins & Penems · 22Quinolone Antibacterials · 13Antiinflammatory And Antirheumatic Products · 12Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 8Beta-Lactam Antibacterials, Penicillins · 7Antiglaucoma Preparations And Miotics · 7Antimalarials · 6Gastro · 5Anti-Infective, Ophthalmologicals · 5Antivirals For Systemic Use · 4Antianemic, Iron Preparations · 4

Conditions treated

General Infections · 22Ulcer/Reflux/Flatulence/Acidity · 5High Cholestrol · 2Blood Clot/Thrombotic Disorder · 2Asthma/Allergy · 1Fever · 1Anaemia · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official366 products · Rs 9 – Rs 31,452.29
DVAGO75 products · Rs 29.29 – Rs 2,790
Servaid69 products · Rs 47 – Rs 2,450
Median across source: Rs 300

Regulatory record

3 alerts in the DRAP feed we track.

129. Recall Alert(Class-I) – DIFAM Injection 3ml (Bosch Pharma) – Substandard
2026-01-14
110. Recall Alert (Class-I) – Dexamex Injection (Batch # DX250017)
2025-11-17
Rapid Alert: Falsified / Spurious Cilapen 500mg Injection identified in the market
2023-02-27

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 209 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
MACTER INTERNATIONAL (PVT) LTD. holds 118 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide
Wilshire Laboratories (Private) Limited holds 77 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmoxycillin BaseAnastrozoleArtesunate

Get the full profile for BOSCH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.